- June 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that the previously announced episode of The Human Upgrade with Dave Asprey featuring Justin Kirkland, Chief Scientific Officer of the Company, is now available
Tincidunt mauris, pharetra aliquam in magnis ornare sit mi velit, quis semper ut a malesuada pharetra volutpat euismod vulputate pellentesque et risus in malesuada pellentesque dictumst amet vitae vitae ut phasellus quam et enim feugiat eget mauris aenean eu volutpat, dictum donec gravida nunc egestas viverra justo sed
Medical eligibility depends on health history and licensed doctor review rather than athletic status
5 Heurteaux et al., Nature Neuroscience (2006)TREK-1 knockout produces a depression-resistant phenotype, establishing TREK-1 as an antidepressant target
Sexual Differentiation of Kiss1 Gene Expression in the Brain of the Rat
